Web Market News

The microbiome therapeutics market is expected to reach USD 433.5 million by 2025 , based on a new study by Grand View Research, Inc. Increasing funding initiatives and government programs to support this research are high impact rendering drivers anticipated to foster market growth. Multiple therapeutic regimens are being followed across the globe in attempts to come up with a reliable treatment for Covid-19. One line of treatment includes the use of hydroxychloroquine, while a second treatment line focuses to use antiviral drugs used in the disease management of HIV. Both these approaches have surged demand from advanced antivirals and antimalarial drugs. This impacts the drug manufacturers as an off label indication for these drug classes has to be worked upon. At the moment, the WHO has not prescribed any of these approaches, neither they have commented if one is better than the other. The report will account for Covid19 as a key market contributor. The launch of Human Microbio...

The global blood glucose monitoring devices market size is expected to reach USD 17.8 billion by 2026 , according to a new report by Grand View research, Inc., registering a 7.1% CAGR over the forecast period. The market is propelled by rising prevalence of diabetes worldwide and increasing geriatric population. Moreover, growing awareness about diabetes preventive care and new product launches are expected to boost the market. With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, se...

The global biotechnology services outsourcing market is expected to reach USD 92.9 billion by 2025 , according to a new report by Grand View Research, Inc. Pharmaceutical industry has been adaptive of the function of outsourcing certain clinical and corporate functions as early as 2002. Among the services outsourced, clinical trial management and contract manufacturing were the forerunners. For instance, Johnson & Johnson was the first pharmaceutical company to outsource its applications development and maintenance (ADM). Multiple therapeutic regimens are being followed across the globe in attempts to come up with a reliable treatment for Covid-19. One line of treatment includes the use of hydroxychloroquine, while a second treatment line focuses to use antiviral drugs used in the disease management of HIV. Both these approaches have surged demand from advanced antivirals and antimalarial drugs. This impacts the drug manufacturers as an off label indication for these drug c...

The global Augmented Reality (AR) & Virtual Reality (VR) in healthcare market size was valued at USD 568.7 million in 2016 and is projected to grow at a CAGR of 29.1% during the forecast period. The growing integration of technology & digitalization in healthcare, increasing healthcare expenditure & focus on delivery of efficient health services, and its significance in training healthcare professionals are some of the key factors driving the increasing adoption of AR and VR technologies. These technologies have revolutionized the healthcare industry with their adoption in virtual training of surgeons for difficult surgeries, 3D operating room simulations, phobia buster in mental health treatment, and chronic pain management. VR technology has also played a significant role in Eye Movement Desensitization and Reprocessing (EMDR) therapy that enables to reframe traumatic memories through certain eye movements. In addition, this technology offers benefits in various ...

First impression is the last impression, and with regards to physical appearance, consumers are taking this age-old adage very seriously now. How does it benefit the dental X-ray market? The global dental X-ray market size is expected to reach USD 2.4 billion by 2024 , according to a new report by Grand View Research, Inc. The market is anticipated to witness lucrative growth during the period 2016 - 2024. This growth is attributed to a majority of factors concerning the prevalence of oral diseases worldwide . With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid accelerat...

The global clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genes market size is expected to reach USD 4.88 billion by 2027 , expanding at a CAGR of 16.6% from 2020 to 2027 , according to a new report by Grand View Research, Inc. Rise in the adoption of CRISPR technology in epigenetics, therapeutics, human germline editing, plant genome editing, and other fields of biotechnology is expected to drive the market. Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated ...

The global attention deficit hyperactivity disorder market size is expected to reach USD 24.9 billion by 2025, based on a new report by Grand View Research, Inc., exhibiting a 6.4% CAGR during the forecast period. Increase in awareness regarding ADHD among patients, physicians, and other healthcare providers is likely to up demand for effective treatment, in turn, propelling market growth. Multiple therapeutic regimens are being followed across the globe in attempts to come up with a reliable treatment for Covid-19. One line of treatment includes the use of hydroxychloroquine, while a second treatment line focuses to use antiviral drugs used in the disease management of HIV. Both these approaches have surged demand from advanced antivirals and antimalarial drugs. This impacts the drug manufacturers as an off label indication for these drug classes has to be worked upon. At the moment, the WHO has not prescribed any of these approaches, neither they have commented if one is ...